Skip to main content

Panacea Biotec

Panacea Biotec is a progressive, Innovative biotechnology company in India with high focus on R&D, Manufacturing, Marketing of Pharmaceuticals, Vaccines and Biosimilars. We specialize in complex generics, vaccines, and novel drug delivery platforms to offer higher value and better health outcomes for our patients, governments, and overall society.


We has a rich experience of > four decades in vaccines and have significantly contributed to global immunization programs  of Developing Countries


Our manufacturing capabilities are recognized by major regulatory bodies through accreditations such as WHO, USFDA, UK MHRA, Saudi FDA, ANVISA, etc. 


Our state-of-art production facilities are located in Baddi (HP) and Lalru (Punjab) with capabilities for Drug Substance and Drug Product for cell-culture, viral recombinant, bacterial proteins, and recombinant bacterial vaccines. We also have a dedicated monoclonal antibody manufacturing facility for mammalian cell-culture related products.


Our R&D programs are backed by distinguished, ultra-modern, state-of-art centres with over 300 scientists with deep roots within the academic community in important clusters in India, US, and Germany. We have over 1,400 patent filings in over 68 countries. 382 granted patents are under various stages of examination or publication in countries USA, Germany, Mexico, Brazil, Australia, South Africa, Japan, Russia, Canada, Ukraine, Korea, China, etc.